Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SCIB.STthis companySciBase Holding AB (publ)	SEK 11.35	-1.43×	18.68×	3.07×	-1.53×	-6261.4%	67.0%	-210.5%	-215.2%	-1308.0%	-286.9%	-68.2%	3.46×	-0.01×	-89.38×	1.92×	0.0%	2	-17.38	1	D+
ARCOMA.STArcoma AB	SEK 8.50	20.97×	1.41×	0.8×	4.36×	-14.6%	5.2%	6.6%	3.8%	6.7%	9.3%	12.5%	0×	-2.2×	73.58×	3.49×	0.0%	6	6.68	3	B+
BIOVIC-B.STBiovica International AB (publ)	SEK 0.31	-1.17×	0.95×	6.14×	-0.26×	-1052.3%	-523.5%	-523.5%	-522.1%	-80.9%	-76.5%	-77.0%	0.05×	1.07×	-176.89×	4.3×	0.0%	3	-9.24	2	C
HEART.STScandinavian Real Heart AB (Publ)	SEK 16.05	-1.96×	1.11×	0×	-3.8×	-85.9%	0.0%	0.0%	0.0%	-56.8%	-22.9%	-23.8%	0.07×	0.8×	-41.14×	2.5×	0.0%	3	8.38	2	C
ICO.STIconovo AB (publ)	SEK 1.10	-1×	0.37×	39.24×	-1.23×	-96.0%	-3959.5%	-3959.5%	-3924.3%	-36.8%	-36.0%	-106.0%	0.04×	0.05×	-97.45×	1.01×	0.0%	4	4.35	2	C+
IMMNOV.STImmunovia AB	SEK 0.03	-0.54×	1.21×	114.1×	-0.02×	293.5%	-11606.4%	-11606.4%	-21301.5%	-225.4%	-108.4%	-100.3%	0.01×	0.99×	-1.2×	5.12×	0.0%	1	-42.87	2	C+
Peer median	—	-1×	1.11×	6.14×	-0.26×	-85.9%	-523.5%	-523.5%	-522.1%	-56.8%	-36.0%	-77.0%	0.04×	0.8×	-41.14×	3.49×	0.0%	3	4.35	2	—